Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
about
Role of platelets in neuroinflammation: a wide-angle perspectiveA CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.Peptides and peptidomimetics as immunomodulators.Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivoPeptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoHER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cellsPeptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyImmunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancerThe apoptotic pathway as a therapeutic target in sepsisCD40 and autoimmunity: the dark side of a great activator.Emerging immunopharmacological targets in multiple sclerosis.Nanomaterials, Autophagy, and Lupus Disease.Induction of an altered CD40 signaling complex by an antagonistic human monoclonal antibody to CD40.Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation.IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics.Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease.
P2860
Q28393808-4AF208C3-EBFF-4573-9FC1-601E1DC2EACCQ34283011-9850BD0C-3EE1-4E0F-8525-B0301154649EQ34359984-00141CFE-B411-4A4C-B3CF-3B50BC36E542Q34787415-CF8AE05E-DC92-4236-A3D7-80ADDD818666Q34787422-DB35412B-137E-4F72-AE49-A4D17B06B9A0Q35073267-AD5BD694-0C6B-437D-9088-091EC7FF6A79Q35201923-277546CC-5822-4463-9F9A-AD1F7AD32B77Q36116250-629820CE-7CC8-4E1C-A832-00295E2C9050Q36388489-AAC1D866-F2AA-4BE0-95F3-6D25E84FC975Q36789484-15BF1035-742C-4804-B3E3-FA1B525DB0D4Q37365433-F1A24D97-587C-4731-91A3-23376A1C5792Q37559970-FCA1EFA1-96E7-4DAE-9D36-500BED9322F9Q38551098-BA5CA134-ADC9-4D98-965E-9B79F24CB9ABQ38896847-D2DA754A-F80A-448D-A29E-CEFD7DA07EEBQ40159236-0E4DDD52-AC92-48ED-884E-4937233F2947Q42107855-BE02CAC5-4D86-47DB-A18D-CE8C9A5B81EDQ47661976-9015453C-730D-4818-904D-39968D49F55AQ48140622-E059E175-6365-4150-A458-616DFB8FBBA6Q52605789-2D4A5E57-A3F0-4A64-9D66-832F986C8789
P2860
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@ast
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@en
type
label
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@ast
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@en
prefLabel
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@ast
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@en
P2093
P2860
P1476
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
@en
P2093
P2860
P304
P356
10.1111/J.1399-3011.2005.00256.X
P577
2005-06-01T00:00:00Z